2a82
Legal Notices
Limited License and Disclaimer for Fluidigm Systems with Fluidigm IFCs
Except as expressly set forth herein, no right to copy, modify, distribute, make derivative works of, publicly display, make, have made, offer to sell, sell, use, or import a Fluidigm system or any other product is conveyed or implied with the purchase of a Fluidigm system (including the BioMark System, EP1 System, FC1 Cycler, or any components thereof), and Access Array IFCs, Dynamic Array IFCs and Digital Array IFCs (integrated fluidic circuits/microfluidic chips with or without a carrier), IFC controller, software, reagents, or any other items provided hereunder. This limited license permits only the use by the buyer of the particular product(s), in accordance with the written instructions provided therewith in the User Guide, that the buyer purchases from Fluidigm or its authorized representative(s). Except to the extent expressly approved in writing by Fluidigm or its authorized representative(s), the purchase of any Fluidigm product(s) does not by itself convey or imply the right to use such product(s) in combination with any other product(s). In particular, (i) no right to make, have made, or distribute other instruments, Access Array IFCs, Dynamic Array IFCs and Digital Array IFCs, software, or reagents is conveyed or implied by the purchase of the Fluidigm system, (ii) no right to make, have made, import, distribute, or use the Fluidigm system is conveyed or implied by the purchase of instruments, software, reagents, Digital Array IFCs from Fluidigm or otherwise, and (iii) except as expressly provided in the User Guide, the buyer may not use and no right is conveyed to use the Fluidigm system in combination with instruments, software, reagents, or Access Array IFCs, Dynamic Array IFCs and Digital Array IFCs unless all component parts have been purchased from Fluidigm or its authorized representative(s). For example, purchase of a Fluidigm system and/or the IFC controller conveys no right or license to patents covering the Access Array IFCs, Dynamic Array IFCs and Digital Array IFCs or their manufacture, such as 6,408,878, 6,645,432, 6,719,868, 6,793,753, 6,929,030, 7,494,555, 7,476,363, 7,601,270, 7,604,965, 7,666,361, 7,691,333, 7,749,737, 7,815,868, 7,867,454, 7,867,763, 8,157,434, 8,163,492; and EP Patent No. 1065378. Fluidigm IFCs may not be used with any non-Fluidigm reader, and Fluidigm readers may not be used with any chip other than Fluidigm IFCs. Fluidigm IFCs are single use only and may not be reused unless otherwise specifically authorized in writing by Fluidigm. All Fluidigm products are licensed to the buyer for research use only. The products do not have FDA or other similar regulatory body approval. The buyer may not use the Fluidigm system, any component parts thereof, or any other Fluidigm products in any setting requiring FDA or similar regulatory approval or exploit the products in any manner not expressly authorized in writing by Fluidigm in advance. No other licenses are granted, expressed or implied.
Fluidigm, the Fluidigm logo, Access Array, AutoInspeX , BioMark, C1, Crystal Vision , DELTAgene, Dynamic Array, Digital Array, EP1, FC1, Fluidline, MSL, NanoFlex, SNPtype, and TOPAZ, and are trademarks or registered trademarks of Fluidigm Corporation in the U.S. and/or other countries. The GOOD DESIGN service mark is used under license from and is the property of The Chicago Athenaeum: Museum of Architecture and Design. All other trademarks are the property of their respective owners. © Fluidigm Corporation. All rights reserved.
All Fluidigm products are for Research Use Only. Not for use in diagnostic procedures.
Fluidigm Product Patent Notice
Fluidigm products including IFCs (integrated fluidic circuits/microfluidic chips with or without a carrier) such as Access Array IFCs, Dynamic Array IFCs and Digital Array IFCs, the IFC controller, FC1 Cycler and the Fluidigm system (BioMark System, EP1 System, readers, thermal cycler, etc.) and methods for reading and controlling the Access Array IFCs, Dynamic Array IFCs and Digital Array IFCs and/or their use and manufacture may be covered by one or more of the following patents owned by Fluidigm Corporation and/or sold under license from California Institute of Technology and other entities: U.S. Patent Nos. 6,408,878, 6,645,432, 6,719,868, 6,793,753, 6,929,030, 7,195,670, 7,216,671, 7,307,802, 7,323,143, 7,476,363, 7,479,186, 7,494,555, 7,588,672, 7,601,270, 7,604,965, 7,666,361, 7,691,333, 7,704,735, 7,749,737, 7,766,055, 7,815,868, 7,837,946, 7,867,454, 7,867,763, 7,906,072, 8,048,378, 8,105553, 8,105,824, 8,157,434, 8163,492; EP Patent Nos. 1065378, 1194693, 1195523 and 1345551; and additional issued and pending patents in the U.S. and other countries.
C1™ products including IFCs (integrated fluidic circuits/microfluidic chips with or without a carrier) such as C1 Single-Cell Auto Prep Array IFCs, the C1 Single-Cell Auto Prep System and methods for controlling the C1, Dynamic Array™, Digital Array™, and/or Access Array™ IFCs and/or their use and manufacture may be covered by one or more of the following patents owned by Fluidigm Corporation and/or sold under license from California Institute of Technology and other entities: U.S. Patent Nos. 6,408,878, 6,645,432, 6,719,868, 6,793,753, 6,929,030, 7,216,671, 7,323,143, 7,476,363, 7,494,555, 7,601,270, 7,604,965, 7,666,361, 7,704,735, 7,749,737, 7,766,055, 7,837,946, 7,867,454, 7,867,763, 8,104,497, 8,104,515, 8,105,553, 8,105,824, 8,129,176, 8,157,434, 8,163,492; EP Patent Nos. 1065378, 1194693, 1195523 and 1345551; and additional issued and pending patents in the U.S. and other countries.
TOPAZ products including TOPAZ screening chips (integrated fluidic circuits (IFCs)/microfluidic chips with or without a carrier), the 1.96 Diffraction Capable chip, the 4.96 screening chip, the IFC controller, the AutoInspeX II workstation, the Image Acquisition, AutoProcessor, and Crystal Vision software, TOPAZ Database Suite software and methods for reading and controlling the TOPAZ chips and/or their use and manufacture may be covered by one or more of the following patents and patent applications owned by Fluidigm Corporation and/or sold under license from California Institute of Technology and other entities: U.S. Patent Nos. 6,408,878, 6,719,868, 6,793,753, 7,040,338, 7,052,545, 7,195,670, 7,214,540, 7,216,671, 7,217,321, 7,247,490, 7,306,296, 7,306,672, 7,494,555, 7,583,853, 7,601,270, 7,670,429, 7,766,055, 7,867,763, 7,974,380; EP Patent Nos. 1065378, 1194693, 1195523; and additional issued and pending patents in the U.S. and other countries.